605 692
[16]
Miki J, Yanagisawa T, Urabe F, et al. Intraoperative fluorescence imaging with indocyanine green for sentinel lymph nodes for prostate cancer during laparoscopic radical prostatectomy. J Urol 2016;195(4 Suppl):e1037.[17]
Grasso M, Vlanco S, Grasso AA, et al. Radio guided radical prosta- tectomy: evaluation of feasibility, safety and clinical outcomes. Minerva Urol Nefrol 2016;68:3–8.[18]
Van den Bergh L, Joniau S, Haustermans K, et al. Reliability of sentinel node procedure for lymph node staging in prostate cancer patients at high risk for lymph node involvement. Acta Oncol 2015;54:896–902.[19]
Brenot-Rossi I, Rossi D, Esterni B, Brunelle S, Chuto G, Bastide C. Radioguided sentinel lymph node dissection in patients with local- ised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure. Eur J Nucl Med Mol Imaging 2008;35:32–8.
[20]
Fukuda M, Egawa M, Imao T, Takashima H, Yokoyama K, Namiki M. Detection of sentinel node micrometastasis by step section and immunohistochemistry in patients with prostate cancer. J Urol 2007;177:1313–7.[21]
Hacker A, Jeschke S, Leeb J, et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [ 18 F ]fluorocholine positron emission tomography- computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2006;176:2014–9.[22]
Hinev AI, Klissarova A, Ghenev P, et al. Radioisotopic detection of sentinel lymph nodes in clinically localized high-risk prostate cancer. J BUON 2009;14:661–7.
[23]
KleinJan GH, van den Berg NS, Brouwer AR, et al. Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer. Eur Urol 2014;66:991–8.[24]
Kjolhede H, Bratt O, Gudjonsson S, Sundqvist P, Liedberg F. Simpli- fied intraoperative sentinel-node detection performed by the urol- ogist accurately determines lymph-node stage in prostate cancer. Scand J Urol 2015;49:97–102.[25]
Manny TB, Patel M, Hemal AK. Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tis- sue marking with percutaneous injection of unconjugated indo- cyanine green: the initial clinical experience in 50 patients. Eur Urol 2014;65:1162–8.
[26]
MeinhardtW, Valdes Olmos RA, VanDer Poel HG, Bex A, Horenblas S. Laparoscopic sentinel node dissection for prostate carcinoma: technical and anatomical observations. BJU Int 2008;102:714–7.
[27]
Muck A, Langesberg C, Mugler M, Rahnenfu¨ hrer J, Wullich B, Schafhauser W. Clinical outcome of patients with lymph node- positive prostate cancer following radical prostatectomy and extended sentinel lymph node dissection. Urol Int 2015;94: 296–306.[28]
Ponholzer A, Lamche M, Klitsch M, et al. Sentinel lymphadenecto- my compared to extended lymphadenectomy in men with pros- tate cancer undergoing prostatectomy. Anticancer Res 2012;32: 1033–6.
[29]
Rousseau C, Rousseau T, Campion L, et al. Laparoscopic sentinel lymph node versus hyperextensive pelvic dissection for staging clinically localized prostate carcinoma: a prospective study of 200 patients. J Nucl Med 2014;55:753–8.
[30]
Schilling D, Boekeler U, Gakis G, et al. Modified concept for radio- isotope-guided sentinel lymph node dissection in prostate cancer. World J Urol 2010;28:715–20.
[31]
Silva Jr N, Anselmi CE, Anselmi OE, et al. Use of the gamma probe in sentinel lymph node biopsy in patients with prostate cancer. Nucl Med Commun 2005;26:1081–6.[32]
Stanik M, Cˇ apa´k I, Macı´k D, et al. Sentinel lymph node dissection combined with meticulous histology increases the detection rate of nodal metastases in prostate cancer. Int Urol Nephrol 2014;46: 1543–9.[33]
Weckermann D, Dorn R, Holl G, Wagner T, Harzmann R. Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 2007;51:1549–58.[34]
Winter A, Woenkhaus J, Wawroschek F. A novel method for intra- operative sentinel lymph node detection in prostate cancer patients using superparamagnetic iron oxide nanoparticles and a handheld magnetometer: the initial clinical experience. Ann Surg Oncol 2014;21:4390–6.
[35]
Yuen K, Miura T, Sakai I, Kiyosue A, Yamashita M. Intraoperative fluorescence imaging for detection of sentinel lymph nodes and lymphatic vessels during open prostatectomy using indocyanine green. J Urol 2015;194:371–7.[36]
Nguyen DP, Huber PM, Metzger TA, Genitsch V, Schudel HH, Thalmann GN. A specific mapping study using fluorescence sentinel lymph node detection in patients with intermediate- and high-risk prostate cancer undergoing extended pelvic lymph node dissection. Eur Urol 2016;70:734–7.[37]
Wawroschek F, Vogt H, Wengenmair H, et al. Prostate lymphos- cintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer: technique and results of the first 350 cases. Urol Int 2003;70:303–10.
[38]
Kluth LA, Abdollah F, Xylinas E, et al. Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment. Br J Cancer 2014;111:213–9.[39]
Holl G, Dorn R, Wengenmair H, Weckermann D, Sciuk J. Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients. Eur J Nucl Med Mol Imaging 2009;36: 1377–82.
[40]
Winter A, Kneib T, Henke RP, Wawroschek F. Sentinel lymph node dissection in more than 1200 prostate cancer cases: rate and prediction of lymph node involvement depending on preoperative tumor characteristics. Int J Urol 2014;21:58–63.
[41]
Winter A, Kneib T, Rohde M, Henke RP, Wawroschek F. First nomogram predicting the probability of lymph node involvement in prostate cancer patients undergoing radioisotope guided senti- nel lymph node dissection. Urol Int 2015;95:422–8.
[42]
Bagaria SP, Faries MB, Morton DL. Sentinel node biopsy in melanoma: technical considerations of the procedure as per- formed at the John Wayne Cancer Institute. J Surg Oncol 2010;101:669–76.[43]
Mattei A, Fuechsel FG, Bhatta Dhar N, et al. The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study. Eur Urol 2008;53:118–25.
[44]
Amr D, Broderick-Villa G, Haigh PI, Guenther JM, DiFronzo LA. Adverse drug reactions during lymphatic mapping and sentinel lymph node biopsy for solid neoplasms. Am Surg 2005;71: 720–4.[45]
Grischke EM, Ro¨hm C, Hahn M, Helms G, Brucker S, Wallwiener D. ICG fluorescence technique for the detection of sentinel lymph nodes in breast cancer: results of a prospective open-label clinical trial. Geburtshilfe Frauenheilkd 2015;75:935–40.
[46]
Sadeghi R, Tabasi KT, Bazaz SM, et al. Sentinel node mapping in the prostate cancer. Meta-analysis. Nuklearmedizin 2011;50: 107–15.[47]
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007;7:10.E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 5 9 6 – 6 0 5
605